Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP410338.RARRrPVvCtaBtauaJoMeflgmaFdBCaNDOrTv0DbwEODRg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP410338.RARRrPVvCtaBtauaJoMeflgmaFdBCaNDOrTv0DbwEODRg130_assertion type Assertion NP410338.RARRrPVvCtaBtauaJoMeflgmaFdBCaNDOrTv0DbwEODRg130_head.
- NP410338.RARRrPVvCtaBtauaJoMeflgmaFdBCaNDOrTv0DbwEODRg130_assertion description "[Taken together, our results reveal that PI3K/Akt signaling pathway inhibition may serve as a novel molecular mechanism in LNCaP prostate cancer cells of PSMA knockdown and suggest that Akt (Ser473) may play a critical role as a downstream signaling target effector of PSMA in this cellular model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410338.RARRrPVvCtaBtauaJoMeflgmaFdBCaNDOrTv0DbwEODRg130_provenance.
- NP410338.RARRrPVvCtaBtauaJoMeflgmaFdBCaNDOrTv0DbwEODRg130_assertion evidence source_evidence_literature NP410338.RARRrPVvCtaBtauaJoMeflgmaFdBCaNDOrTv0DbwEODRg130_provenance.
- NP410338.RARRrPVvCtaBtauaJoMeflgmaFdBCaNDOrTv0DbwEODRg130_assertion SIO_000772 24571890 NP410338.RARRrPVvCtaBtauaJoMeflgmaFdBCaNDOrTv0DbwEODRg130_provenance.
- NP410338.RARRrPVvCtaBtauaJoMeflgmaFdBCaNDOrTv0DbwEODRg130_assertion wasDerivedFrom befree-20150227 NP410338.RARRrPVvCtaBtauaJoMeflgmaFdBCaNDOrTv0DbwEODRg130_provenance.
- NP410338.RARRrPVvCtaBtauaJoMeflgmaFdBCaNDOrTv0DbwEODRg130_assertion wasGeneratedBy ECO_0000203 NP410338.RARRrPVvCtaBtauaJoMeflgmaFdBCaNDOrTv0DbwEODRg130_provenance.